Marinus Pharmaceuticals Stock Technical Analysis
MRNS Stock | USD 1.44 0.04 2.70% |
As of the 23rd of April, Marinus Pharmaceuticals secures the Risk Adjusted Performance of (0.07), standard deviation of 10.96, and Mean Deviation of 4.0. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Marinus Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Marinus Pharmaceuticals, which can be compared to its peers in the industry. Please verify Marinus Pharmaceuticals market risk adjusted performance and treynor ratio to decide if Marinus Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 1.44 per share. Please also check out Marinus Pharmaceuticals jensen alpha, which is currently at (1.73) to check the company can sustain itself at a future point.
Marinus Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Marinus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MarinusMarinus |
Marinus Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
20.9 | Strong Buy | 11 | Odds |
Most Marinus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Marinus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Marinus Pharmaceuticals, talking to its executives and customers, or listening to Marinus conference calls.
Marinus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Marinus Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Marinus Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Marinus Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Marinus Pharmaceuticals. You can use it to identify possible trend reversals for Marinus Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Marinus Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Marinus Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Marinus Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.11 , which may suggest that Marinus Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 426.38, which is the sum of squared deviations for the predicted Marinus Pharmaceuticals price change compared to its average price change.About Marinus Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Marinus Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Marinus Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Marinus Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Marinus Pharmaceuticals. By analyzing Marinus Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Marinus Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Marinus Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2023 | 2024 (projected) | Days Sales Outstanding | 75.78 | 44.75 | 42.51 | PTB Ratio | 8.15 | 34.85 | 36.59 |
Marinus Pharmaceuticals April 23, 2024 Technical Indicators
Most technical analysis of Marinus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Marinus from various momentum indicators to cycle indicators. When you analyze Marinus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.07) | |||
Market Risk Adjusted Performance | (0.30) | |||
Mean Deviation | 4.0 | |||
Coefficient Of Variation | (800.00) | |||
Standard Deviation | 10.96 | |||
Variance | 120.05 | |||
Information Ratio | (0.13) | |||
Jensen Alpha | (1.73) | |||
Total Risk Alpha | (2.79) | |||
Treynor Ratio | (0.31) | |||
Maximum Drawdown | 92.15 | |||
Value At Risk | (5.19) | |||
Potential Upside | 5.31 | |||
Skewness | (6.35) | |||
Kurtosis | 48.4 |
Marinus Pharmaceuticals April 23, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Marinus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 294,460 | ||
Daily Balance Of Power | (0.25) | ||
Rate Of Daily Change | 0.97 | ||
Day Median Price | 1.48 | ||
Day Typical Price | 1.47 | ||
Price Action Indicator | (0.06) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marinus Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Marinus Stock please use our How to Invest in Marinus Pharmaceuticals guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Marinus Stock analysis
When running Marinus Pharmaceuticals' price analysis, check to measure Marinus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marinus Pharmaceuticals is operating at the current time. Most of Marinus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Marinus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marinus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Marinus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Marinus Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marinus Pharmaceuticals. If investors know Marinus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marinus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.63) | Revenue Per Share 0.577 | Quarterly Revenue Growth 0.004 | Return On Assets (0.38) | Return On Equity (2.13) |
The market value of Marinus Pharmaceuticals is measured differently than its book value, which is the value of Marinus that is recorded on the company's balance sheet. Investors also form their own opinion of Marinus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Marinus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marinus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Marinus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marinus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marinus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marinus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.